留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Overexpression of Jak1 Activating Mutants in Hepatocytes Is Insufficient to Generate Hepatocellular Carcinoma in Zebrafish

Yue Yuan Jian Zhang Qin Zhou

Yue Yuan, Jian Zhang, Qin Zhou. Overexpression of Jak1 Activating Mutants in Hepatocytes Is Insufficient to Generate Hepatocellular Carcinoma in Zebrafish[J]. Journal of Genetics and Genomics, 2016, 43(2): 99-102. doi: 10.1016/j.jgg.2015.11.003
Citation: Yue Yuan, Jian Zhang, Qin Zhou. Overexpression of Jak1 Activating Mutants in Hepatocytes Is Insufficient to Generate Hepatocellular Carcinoma in Zebrafish[J]. Journal of Genetics and Genomics, 2016, 43(2): 99-102. doi: 10.1016/j.jgg.2015.11.003

doi: 10.1016/j.jgg.2015.11.003

Overexpression of Jak1 Activating Mutants in Hepatocytes Is Insufficient to Generate Hepatocellular Carcinoma in Zebrafish

More Information
  • [1] Farazi, P.A., DePinho, R.A. Hepatocellular carcinoma pathogenesis: from genes to environment Nat. Rev. Cancer, 6 (2006),pp. 674-687
    [2] Fatima, S., Lee, N.P., Luk, J.M. Dickkopfs and Wnt/β-catenin signaling in liver cancer World J. Clin. Oncol., 2 (2011),pp. 311-325
    [3] He, G., Karin, M. NF-κB and STAT3 – key players in liver inflammation and cancer Cell Res., 21 (2011),pp. 159-168
    [4] Hong, S., Laimins, L.A. The JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiation PLoS Pathog., 9 (2013),p. e1003295
    [5] Hsu, I.C., Metcalf, R.A., Sun, T. et al. Mutational hotspot in the p53 gene in human hepatocellular carcinomas Nature, 350 (1991),pp. 427-428
    [6] Hussain, S.P., Schwank, J., Staib, F. et al. Oncogene, 26 (2007),pp. 2166-2176
    [7] Jemal, A., Bray, F., Center, M.M. et al. Global cancer statistics CA Cancer J. Clin., 61 (2011),pp. 69-90
    [8] Kan, Z., Zheng, H., Liu, X. et al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma Genome Res., 23 (2013),pp. 1422-1433
    [9] Liberzon, A., Subramanian, A., Pinchback, R. et al. Molecular signatures database (MSigDB) 3.0 Bioinformatics, 27 (2011),pp. 1739-1740
    [10] Nguyen, A.T., Emelyanov, A., Koh, C.H. et al. Dis. Model. Mech., 4 (2011),pp. 801-813
    [11] Parkin, D.M. The global health burden of infection-associated cancers in the year 2002 Int. J. Cancer, 118 (2006),pp. 3030-3044
    [12] Vogelstein, B., Kinzler, K.W. The multistep nature of cancer Trends Genet., 9 (1993),pp. 138-141
    [13] Wei, Y., Van Nhieu, J.T., Prigent, S. et al. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, β-catenin expression, and clinical features Hepatology, 36 (2002),pp. 692-701
    [14] Whittaker, S., Marais, R., Zhu, A.X. The role of signaling pathways in the development and treatment of hepatocellular carcinoma Oncogene, 29 (2010),pp. 4989-5005
  • 加载中
计量
  • 文章访问数:  109
  • HTML全文浏览量:  38
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-09-14
  • 录用日期:  2015-11-08
  • 修回日期:  2015-10-28
  • 网络出版日期:  2016-01-22
  • 刊出日期:  2016-02-20

目录

    /

    返回文章
    返回